Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Prevention of recurrent miscarriages through administration of fibroblasts and fibroblast-educated paternal cells

Prevention of recurrent miscarriages through administration of fibroblasts and fibroblast-educated paternal cells

US Patent 12404494 · Granted Sep 2, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of cerebral palsy using fibroblasts2025
Treatment of cerebral palsy using fibroblasts2025
Adipose cells for chondrocyte applications2025
Prevention and/or treatment of type 1 diabetes by augmentation of myeloid suppre2025
Treatment of heart failure and/or post infarct pathological remodeling by ex viv2025
Stimulation of angiogenesis by fibroblast derived exosomes2025
Stimulation of angiogenesis by fibroblast derived exosomes2025
Interaction of fibroblasts and immune cells for activation and uses thereof2025
Interaction of fibroblasts and immune cells for activation and uses thereof2025
Treatment of opioid addiction using fibroblasts and products thereof2024
Treatment of opioid addiction using fibroblasts and products thereof2024
Fibroblast therapy for treatment of Duchenne muscular dystrophy2024